To listen to individual tracks, click on the track you wish to listen to. To download tracks, right-click on the one you wish to download.
Track 1 Case 1 presented to: Drs Hudis and Swain	Case from the practice of Kenneth K Ng, MD A 59-year-old postmenopausal woman treated three years ago for a 2-cm, ER- and PR-positive, HER2-negative, node-positive infiltrating ductal carcinoma (IDC) presents with widespread, biopsy-confirmed bone and lung metastases.
Track 2 Case 2 presented to: Drs Hudis and Swain	Case from the practice of Martha A Tracy, MD A 56-year-old postmenopausal woman with poorly controlled diabetes, hypertension and cardiomyopathy with a 49 percent LVEF presents with a 5.3-cm, ER- and PR-positive, HER2-positive IDC.
Track 3 Case 3 presented to: Drs Hudis and Swain	Case from the practice of Scott A Tetreault, MD A 62-year-old woman underwent a mastectomy for a 5-cm, ER-positive, PR-negative, HER2-positive IDC with 2/13 positive lymph nodes.
Track 4 Case 4 presented to: Drs Hudis and Swain	Case from the practice of Brenda Towell, MD A 42-year-old woman postoophorectomy presented with a well-differentiated, 9-mm, ER-positive, PR-negative, HER2-negative BC with cytokeratin-positive cells in one sentinel node.
Track 5 Case 5 presented to: Drs Hudis and Swain	Case from the practice of Margaret A Deutsch, MD An 81-year-old woman noncompliant with adjuvant letrozole presents with a locally recurrent, Grade III, 5-mm, ER- and PR-positive, HER2-negative BC 18 months after initial treatment.
Track 6 Case 6 presented to: Drs Miller, Perez and Winer	Case from the practice of Alan B Astrow, MD A 71-year-old woman has a 5.2-cm residual invasive lobular carcinoma with involvement of the nipple and 19/22 positive nodes after neoadjuvant TC and mastectomy for three ER- and PR-positive, HER2-negative BCs
Track 7 Case 7 presented to: Drs Miller, Perez and Winer	Case from the practice of Patricia A De Fusco, MD A 58-year-old woman presents with symptomatic pleural effusion and ER-positive, PR-borderline, HER2-negative cells consistent with BC 11 years after initial treatment for an IDC with 14/15 positive nodes.
Track 8 Case 8 presented to: Drs Miller, Perez and Winer	Case from the practice of Dean G Tsarwhas, MD A 50-year-old perimenopausal woman underwent bilateral mastectomies for a well-differentiated, 1.4- x 0.7-cm, strongly ER- and PR-positive, HER2-negative IDC with a small (>2-mm) focus of metastatic cells in one sentinel node.
BONUS AUDIO AVAILABLE EXCLUSIVELY ONLINE
Track 9 Case 9 presented to: Drs Hudis and Swain	Case from the practice of Susan L Luedke, MD A 45-year-old woman with long-term disease control from adjuvant hormonal therapy after intensive treatment for a large, poorly differentiated ER- and PR-positive, node-positive BC, a local recurrence and the subsequent development of a contralateral supraclavicular nodal metastasis.
Track 10 Case 10 presented to: Drs Hudis and Swain	Case from the practice of Gary Steinecker, MD A 77-year-old woman was treated for a 3-cm, triple-negative IDC with skin involvement, 20+ positive lymph nodes, extensive dermal lymphatic invasion and extensive anterior and posterior mediastinal metastases and developed an axillary recurrence two years later.
Track 11 Case 11 presented to: Drs Hudis and Swain	Case from the practice of Dr Tsarwhas A 60-year-old woman who underwent a mastectomy for two 5-mm, ER- and PR-negative, HER2-positive, node-negative breast cancers.
Track 12 Case 12 presented to: Drs Miller, Perez and Winer	Case from the practice of Mark S Robbins, MD A 52-year-old woman with a 1.9-cm, Grade III IDC with 11 positive nodes and focal extracapsular extension with multiple discordant pathology reports for ER, PR and HER2 and an Oncotype DX® Recurrence Score® of 34.
Track 13 Case 13 presented to: Drs Miller, Perez and Winer	Case from the practice of Dr Steinecker A 55-year-old woman with a strong family history of breast and colon cancer presented with gastric metastases with lobular carcinoma 12 years after treatment for a 6-cm, ER- and PR-positive infiltrating lobular carcinoma.